Maneesh Pharmaceuticals Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Maneesh Pharmaceuticals Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $31.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Maneesh Pharmaceuticals Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $31.9M Trade | TransData Nexus

Maneesh Pharmaceuticals Limited

Indian Pharmaceutical Exporter · Tuberculosis Medications Specialist · $31.9M Total Trade · DGFT Verified

Maneesh Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $31.9M across 6 products in 4 therapeutic categories. Based on 651 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Rifampicin ($11.2M), Isoniazid ($10.1M), Ethambutol ($5.0M).

Maneesh Pharmaceuticals Limited — Export Portfolio & Destination Treemap

Maneesh Pharmaceuticals Limited pharmaceutical export portfolio — 6 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Maneesh Pharmaceuticals Limited? — Company Overview & Market Position

Maneesh Pharmaceuticals Limited, established on July 25, 1985, is a public limited company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH1985PLC036952. With an authorized capital of ₹30.00 crore and a paid-up capital of ₹28.13 crore, Maneesh Pharmaceuticals operates in the manufacturing sector, focusing on drug formulation and development.

The company's registered office is located at 29/33, Ancillary Industrial Plots, Govandi, Mumbai, Maharashtra, 400043, India. As of the latest available data, Maneesh Pharmaceuticals employs approximately 1,204 professionals. The company's website is www.maneeshpharma.com.

What Does Maneesh Pharmaceuticals Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Rifampicin$11.2M 2Isoniazid$10.1M

Product Portfolio — Top 6 by Export Value

Maneesh Pharmaceuticals Limited exports 6 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Rifampicin	Advanced Antibiotics	$11.2M	224	0.8%	4
2	Isoniazid	Tuberculosis Medications	$10.1M	202	0.4%	4
3	Ethambutol	Tuberculosis Medications	$5.0M	100	0.4%	6
4	Pyrazinamide	Tuberculosis Medications	$3.9M	77	0.4%	4
5	Strip	Medical Devices & Diagnostics	$1.7M	34	0.9%	2
6	Primaquine	Antimalarial & Antiparasitic	$22.9K	14	1.4%	10

Maneesh Pharmaceuticals Limited exports 6 pharmaceutical products across 4 therapeutic categories with a total export value of $31.9M. The top category is Tuberculosis Medications (59.5% of portfolio), followed by Advanced Antibiotics (35.1%), indicating a concentrated portfolio with the top 5 products accounting for 99.9% of total export value.

Maneesh Pharmaceuticals Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Maneesh Pharmaceuticals operates multiple manufacturing facilities across India, each specializing in different pharmaceutical formulations. The primary manufacturing units include:

Unit I: Located at Plot No. 40, Ancillary Industrial Plots, Govandi, Mumbai, this facility specializes in tablets, capsules, syrups, and injections.

Unit II: Situated at Plot 29-33, Ancillary Industrial Plots, Govandi, Mumbai, this unit focuses on soft gelatin capsules, creams, ointments, and gels.

Unit III: Located at Plot D 16/7, TTC Industrial Area, Turbhe, Navi Mumbai, this facility specializes in tablets, capsules, dry syrups, dry powder injections, and water for injection.

Unit V: Situated at 'T' - 172, MIDC, Bhosari, Pune, this unit focuses on ointments.

Unit VI: Located at Khasra No. 337-340, Village Balyana, Pargana Doon, Barotiwala, Tehsil Kasouli, Dist. Solan, Himachal Pradesh, this facility specializes in tablets, capsules, powders, effervescent tablets, and cephalosporin products.

These facilities adhere to stringent quality standards and hold certifications from regulatory bodies such as WHO, GMP, FDA (USA), MHRA (UK), and others.

3Key Leadership

Maneesh Pharmaceuticals Limited is led by a team of experienced professionals:

Maneesh Ramakant Sapte: Whole-Time Director since October 1, 2002.

Ajit Gopal Jamkhandikar: Director since August 24, 2018.

Pravin Mohandas Hegde: Director since January 19, 2017.

Rakesh Khetan Tunaram: Chief Financial Officer since March 20, 2015.

Rashmi Vinay Sapte: Director since March 30, 2007.

Vinay Ramakant Sapte: Director since July 25, 1985.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Maneesh Pharmaceuticals Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Maneesh Pharmaceuticals Limited has established a significant presence in several regulated markets:

United States: The company holds USFDA approvals for its manufacturing facilities, ensuring compliance with stringent quality standards required for the U.S. market.

European Union and United Kingdom: Maneesh Pharmaceuticals has received approvals from the MHRA (UK) and WHO (Geneva) for its oral solids manufacturing, facilitating access to these markets.

Australia: While specific details are not provided, the company's adherence to WHO and GMP standards suggests potential compliance with Australian regulatory requirements.

Japan: The company's certifications from WHO and GMP indicate a commitment to quality that may align with Japanese regulatory expectations.

These approvals enable Maneesh Pharmaceuticals to market its products in these regions, adhering to their respective regulatory standards.

Emerging Markets

Maneesh Pharmaceuticals Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Maneesh Pharmaceuticals Limited's manufacturing facilities are registered with the U.S. Food and Drug Administration (FDA), indicating compliance with U.S. regulatory requirements. The company has approved Abbreviated New Drug Applications (ANDAs) for its products, facilitating the marketing of generic drugs in the U.S. market. Additionally, the company has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing process, quality control, and other critical aspects of its products. The facilities have undergone FDA inspections, which have been completed satisfactorily, ensuring adherence to Good Manufacturing Practices (GMP).

2WHO & EU GMP

Maneesh Pharmaceuticals Limited's manufacturing facilities hold certifications from the World Health Organization (WHO) and comply with European Union Good Manufacturing Practices (EU GMP). These certifications affirm the company's commitment to maintaining high-quality standards in its manufacturing processes, ensuring the safety and efficacy of its pharmaceutical products.

3CDSCO & Indian Regulatory

Maneesh Pharmaceuticals Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Maneesh Pharmaceuticals Limited operates in a competitive landscape with several key players in the pharmaceutical industry. While specific competitors are not identified in the available data, the company's focus on high-quality manufacturing and adherence to international standards positions it favorably in the market. The company's diversified product portfolio and global presence contribute to its competitive edge.

2Key Differentiators

Maneesh Pharmaceuticals Limited's key differentiators include its state-of-the-art manufacturing facilities with USFDA, MHRA (UK), and WHO (Geneva) approvals, ensuring compliance with stringent international standards. The company's commitment to quality is further demonstrated by its adherence to WHO and EU GMP certifications. Additionally, Maneesh Pharmaceuticals has pioneered initiatives such as hologram and barcoding technologies to ensure medicine authenticity and consumer safety.

3Strategic Position

Maneesh Pharmaceuticals Limited's current strategic direction focuses on expanding its global footprint by exporting finished pharmaceutical formulations to various international markets. The company's adherence to international regulatory standards and commitment to quality manufacturing position it well for future growth. The strategic outlook includes leveraging its manufacturing capabilities and certifications to enter new markets and strengthen its presence in existing ones.

Buyer Due Diligence Brief — Evaluating Maneesh Pharmaceuticals Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Maneesh Pharmaceuticals Limited has a strong track record in the pharmaceutical industry, with a history of exporting finished pharmaceutical formulations to multiple international markets. The company's export volume and consistency are supported by its compliance with international regulatory standards and certifications. Reliability indicators include its adherence to WHO and EU GMP standards, as well as its commitment to quality manufacturing processes.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Maneesh Pharmaceuticals Limited

How many pharmaceutical products does Maneesh Pharmaceuticals Limited export from India?

Maneesh Pharmaceuticals Limited exports 6 pharmaceutical products across 4 therapeutic categories. The top exports are Rifampicin ($11.2M), Isoniazid ($10.1M), Ethambutol ($5.0M), Pyrazinamide ($3.9M), Strip ($1.7M). Total export value is $31.9M.

What is Maneesh Pharmaceuticals Limited's total pharmaceutical export value?

Maneesh Pharmaceuticals Limited's total pharmaceutical export value is $31.9M, based on 651 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Maneesh Pharmaceuticals Limited cover?

Maneesh Pharmaceuticals Limited exports across 4 therapeutic categories. The largest are Tuberculosis Medications (59.5%, 3 products), Advanced Antibiotics (35.1%, 1 products), Medical Devices & Diagnostics (5.3%, 1 products).

Get Full Maneesh Pharmaceuticals Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.